This may already have been posted but good to see continued strong support from Hashan and Karst Peak who were Neuren's largest holders at $1 and are backing the company to be an attractive M&A target.
https://www.linkedin.com/posts/hashan-de-silva_why-analysts-love-these-eight-medtech-stocks-activity-7163321989502283776-z7Ef?utm_source=share&utm_medium=member_desktop
"Neuren Pharmaceuticals Limited has had a very successful 2 years however we still see considerable upside when looking at comparable transactions. Orphan drugs has been a hot area for a while and with neuroscience coming back into focus for big pharma, we see Neuren as an attractive target for M&A."
This may already have been posted but good to see continued...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.18 |
Change
0.120(0.63%) |
Mkt cap ! $2.449B | |||
| Open | High | Low | Value | Volume |
| $19.09 | $19.34 | $18.95 | $5.275M | 275.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 879 | $19.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.21 | 1233 | 1 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.23 |
Change
0.120 ( 0.74 %) |
||||
| Open | High | Low | Volume | ||
| $19.04 | $19.34 | $18.95 | 85422 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| NEU (ASX) Chart |